Yumanity Therapeutics Inc
(YMTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMTX | AZN | AMGN | GILD | BMY |
| Company | Yumanity Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.6300 | 205.60 | 363.68 | 153.10 | 60.12 |
| High | 1.8900 | 206.64 | 366.13 | 153.66 | 60.63 |
| Low | 1.4000 | 204.88 | 362.36 | 152.12 | 60.04 |
| Latest | 1.8900 | 205.02 | 366.18 | 153.38 | 60.25 |
| Change | +0.1500 | +0.50 | +2.50 | +1.57 | +0.39 |
| % Change | +8.62% | +0.24% | +0.69% | +1.03% | +0.65% |
| Volume | 697,400 | 168,991 | 95,114 | 50,984 | 55,359 |
| 20-Day Average Volume | 312,450 | 4,400,425 | 3,097,141 | 8,588,794 | 13,139,838 |
| Previous Close | 1.7400 | 204.52 | 366.20 | 151.81 | 59.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8773 | 189.60 | 353.18 | 141.96 | 57.02 |
| 20-Day Raw Stochastic | 59.76% | 94.71% | 66.66% | 88.14% | 79.19% |
| 20-Day Relative Strength | 52.61 | 65.27 | 59.13 | 68.10 | 65.16 |
| Weighted Alpha | -37.50 | +48.72 | +31.08 | +57.07 | +23.05 |
| Today's Opinion | 96% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 64% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.03% since 12/09/22 | +6.27% since 02/06/26 | -5.29% since 02/06/26 | +0.40% since 02/06/26 | -2.76% since 02/06/26 |
| Low | 1.4000 on 12/16/22 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 2.0900 on 12/13/22 | 206.64 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 61.63 on 02/09/26 |
| 1-Month | |||||
| %Chg | +3.95% since 11/16/22 | +8.52% since 01/13/26 | +12.24% since 01/13/26 | +25.75% since 01/13/26 | +7.80% since 01/13/26 |
| Low | 1.4000 on 12/16/22 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 2.2200 on 12/08/22 | 206.64 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +13.86% since 09/16/22 | +15.75% since 11/13/25 | +8.33% since 11/13/25 | +22.30% since 11/13/25 | +23.96% since 11/13/25 |
| Low | 1.4000 on 12/16/22 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.2200 on 12/08/22 | 206.64 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +20.38% since 06/16/22 | +31.59% since 08/13/25 | +25.80% since 08/13/25 | +27.45% since 08/13/25 | +25.98% since 08/13/25 |
| Low | 1.4000 on 12/16/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 2.2200 on 12/08/22 | 206.64 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,518 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 10,856 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 8,040,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -39,500,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,400,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,360,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.32 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/14/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/23/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |